DJIA 12,278.41; Down 30.84 (0.25%)
NASDAQ 2,427.69; Down 18.17 (0.74%)
S&P500 1,407.29; Down 5.61 (0.40%)
NYSE Volume 2,700,656,000
NASD Volume 2,045,004,000
After a mix & match of comments on a potential XM Satellite & Sirius Satellite, XMSR traded up 0.75% to $14.81 and SIRI traded up 1.3% to $3.88.
Level 3 (LVLT) rose another 3.8% to $5.75 after Cramer was postive again on out and interviewed the CEO. Last night Cramer said it was his best stock under $10.00 out there.
Despite some indications that the FDA would keep the drug coated stents going as they are now, Boston Scientific (BSX) fell 0.3% to $16.94 and J&J (JNJ) rose a whopping $0.03 to $66.06.
Apple (AAPL) fell another 3.1% to $87.04 after research reports indicate that Apple’s iPhone may be delayed by several months.
Eli Lilly (LLY) fell 1.6% to $53.99 as their longer-term guidance is essentially under street targets.
Arena Pharma (ARNA) fell 1.7% to $13.21 ahead of the pricing of its 8M share secondary offering set for tonight.
Vanda Pharma (VNDA) rose a whopping 68% to $26.15, its highest close by far since its IPO, on very positive Schizophrenia studies. Now Schizo’s might not have to say, “I’m a schizophrenic, and so am I.”
Coca-Cola (KO) rose 0.7% to $48.72 after naming a new COO.
AU Optronics (AUO) fell 2.5% to $13.38 after lowering shipment targets.
Corning (GLW) fell almost 4% to $21.05 after comments out of the company were sort of taken by the street that the company was seeing a slowing in demand.
Insmed (INSM) fell another 12% to $1.15 after confirming the patent case loss to Genentech.
Akamai (AKAM) rose 7% to $53.38 on a positive boutique report.
Alcatel-Lucent (ALU) rose 2.6% after Goldman Sachs added it to the Conviction Buy List; although estimates lowered for 2006 and raised for 2007.
The biggest of the little pigs, Gateway (GTW), rose 2% to $1.90 after the company removed a rights program and made it easier for directors to be replaced.
Jon C. Ogg
December 7, 2006
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.